Alpha DNA Investment Management LLC Purchases Shares of 9,023 Trupanion, Inc. (NASDAQ:TRUP)

Alpha DNA Investment Management LLC purchased a new stake in Trupanion, Inc. (NASDAQ:TRUP) in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 9,023 shares of the financial services provider’s stock, valued at approximately $435,000.

Other large investors also recently made changes to their positions in the company. Amundi boosted its stake in Trupanion by 193.2% in the 4th quarter. Amundi now owns 16,828 shares of the financial services provider’s stock worth $784,000 after purchasing an additional 11,088 shares during the period. Barclays PLC boosted its position in shares of Trupanion by 259.2% during the third quarter. Barclays PLC now owns 65,498 shares of the financial services provider’s stock worth $2,750,000 after buying an additional 47,262 shares during the period. Vanguard Group Inc. grew its holdings in shares of Trupanion by 1.3% during the fourth quarter. Vanguard Group Inc. now owns 3,596,725 shares of the financial services provider’s stock worth $173,362,000 after buying an additional 45,653 shares in the last quarter. Wealthfront Advisers LLC acquired a new stake in Trupanion in the 4th quarter valued at approximately $845,000. Finally, Illinois Municipal Retirement Fund bought a new stake in Trupanion in the 4th quarter valued at approximately $834,000.

Insider Transactions at Trupanion

In other Trupanion news, CEO Margaret Tooth sold 2,294 shares of Trupanion stock in a transaction on Tuesday, March 4th. The shares were sold at an average price of $31.39, for a total transaction of $72,008.66. Following the completion of the transaction, the chief executive officer now directly owns 118,784 shares of the company’s stock, valued at $3,728,629.76. The trade was a 1.89 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Fawwad Qureshi sold 1,373 shares of the company’s stock in a transaction on Wednesday, February 26th. The shares were sold at an average price of $34.22, for a total transaction of $46,984.06. Following the completion of the transaction, the chief financial officer now owns 2,416 shares in the company, valued at approximately $82,675.52. This represents a 36.24 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 29,792 shares of company stock worth $989,442. 5.50% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on TRUP shares. Piper Sandler lowered their price objective on shares of Trupanion from $57.00 to $52.00 and set an “overweight” rating on the stock in a report on Thursday, February 20th. Stifel Nicolaus lowered their price target on shares of Trupanion from $44.00 to $41.00 and set a “hold” rating on the stock in a research note on Thursday, February 20th. Two investment analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $46.60.

Trupanion Stock Performance

Shares of TRUP stock opened at $34.72 on Friday. The company has a fifty day moving average price of $36.71 and a two-hundred day moving average price of $45.52. Trupanion, Inc. has a one year low of $19.69 and a one year high of $57.90. The stock has a market cap of $1.48 billion, a P/E ratio of -150.96, a P/E/G ratio of 6.02 and a beta of 1.66. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.71 and a quick ratio of 1.66.

Trupanion (NASDAQ:TRUP) last issued its earnings results on Wednesday, February 19th. The financial services provider reported $0.04 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.06 by ($0.02). Trupanion had a negative net margin of 0.75% and a negative return on equity of 3.08%. The firm had revenue of $337.31 million during the quarter, compared to analyst estimates of $335.41 million. As a group, equities analysts predict that Trupanion, Inc. will post 0.13 EPS for the current year.

Trupanion Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.